# Heated Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Peritoneal Cancer

> **NCT02199171** · PHASE1 · COMPLETED · sponsor: **University of California, Irvine** · enrollment: 30 (actual)

## Conditions studied

- FIGO Stage IIC-IV Ovarian Carcinoma
- Fallopian Tube Carcinoma
- Peritoneal Carcinoma

## Interventions

- **DRUG:** carboplatin

## Key facts

- **NCT ID:** NCT02199171
- **Lead sponsor:** University of California, Irvine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2017-10
- **Final completion:** 2017-10
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2020-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02199171

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02199171, "Heated Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Peritoneal Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02199171. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*